GlassScriptPhysician profile
Christina E Lewicky Gaupp
NPI 1194844019
$3,977.37
in general payments reported to CMS, 2019-2025
8 companies · $316 in 2025
The $316 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.69 · 2021: $2,523 · 2022: $277 · 2023: $354 · 2024: $473 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,142.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $2,200.00 | 2021 | |
| Boston Scientific Corporation | $1,020.36 | 2019-2025 | Advantage System, Solyx Sis System, Upsylon |
| Coloplast Corp | $267.79 | 2023-2024 | Saffron |
| Axonics, INC. | $207.13 | 2021-2023 | Axonics |
| Intuitive Surgical, INC. | $98.62 | 2023 | Da Vinci Surgical System |
| Medtronic, INC. | $67.00 | 2021-2025 | Altaviva |
| Baxter Healthcare | $65.16 | 2025 | Perclot |
| Applied Medical Resources Corporation | $51.31 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Lewicky Gaupp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.